View Future GrowthHanchem Co 過去の業績過去 基準チェック /26Hanchem Coは、平均年間15.3%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 減少しています。収益は、平均年間0.09% 9.6%収益成長率で 減少しています。 Hanchem Coの自己資本利益率は8.8%であり、純利益率は15.9%です。主要情報15.26%収益成長率-14.26%EPS成長率Chemicals 業界の成長13.95%収益成長率-9.64%株主資本利益率8.77%ネット・マージン15.90%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • Nov 19Third quarter 2025 earnings released: EPS: ₩175 (vs ₩373 in 3Q 2024)Third quarter 2025 results: EPS: ₩175 (down from ₩373 in 3Q 2024). Revenue: ₩8.16b (down 18% from 3Q 2024). Net income: ₩1.37b (down 42% from 3Q 2024). Profit margin: 17% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue.すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jul 08Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₩7,470, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 7.7% over the past year.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to ₩10,460, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 23% over the past year.Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩14,320, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 75% over the past year.New Risk • May 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (₩98.8b market cap, or US$65.8m).Valuation Update With 7 Day Price Move • May 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩9,470, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 20% over the past year.New Risk • Mar 27New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 33% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Market cap is less than US$100m (₩67.5b market cap, or US$44.7m).お知らせ • Mar 17Hanchem Co,. Ltd., Annual General Meeting, Mar 27, 2026Hanchem Co,. Ltd., Annual General Meeting, Mar 27, 2026, at 09:30 Tokyo Standard Time. Location: conference room, 35, techno 9-ro, yuseong-gu, daejeon South KoreaValuation Update With 7 Day Price Move • Mar 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,990, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 6.0% over the past year.Buy Or Sell Opportunity • Mar 03Now 24% undervaluedOver the last 90 days, the stock has risen 17% to ₩8,990. The fair value is estimated to be ₩11,773, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 10%.分析記事 • Jan 16Hanchem Co,. Ltd. (KOSDAQ:457370) Stock Rockets 37% As Investors Are Less Pessimistic Than ExpectedHanchem Co,. Ltd. ( KOSDAQ:457370 ) shareholders would be excited to see that the share price has had a great month...分析記事 • Jan 13Hanchem Co (KOSDAQ:457370) Will Be Hoping To Turn Its Returns On Capital AroundWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩9,160, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Negligible returns to shareholders over past year.お知らせ • Dec 03Hanchem Co,. Ltd. announces Annual dividendHanchem Co,. Ltd. announced Annual dividend of KRW 200.0000 per share, ex-date on December 29, 2025 and record date on December 31, 2025.分析記事 • Nov 19There's No Escaping Hanchem Co,. Ltd.'s (KOSDAQ:457370) Muted EarningsWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 14x, you may consider...Reported Earnings • Nov 19Third quarter 2025 earnings released: EPS: ₩175 (vs ₩373 in 3Q 2024)Third quarter 2025 results: EPS: ₩175 (down from ₩373 in 3Q 2024). Revenue: ₩8.16b (down 18% from 3Q 2024). Net income: ₩1.37b (down 42% from 3Q 2024). Profit margin: 17% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue.分析記事 • Jul 14Here's Why Hanchem Co (KOSDAQ:457370) Can Manage Its Debt ResponsiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...お知らせ • Feb 21Hanchem Co,. Ltd., Annual General Meeting, Mar 28, 2025Hanchem Co,. Ltd., Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: conference room, 35, techno 9-ro, yuseong-gu, daejeon South Koreaお知らせ • Feb 04Hanchem Co,. Ltd. (KOSDAQ:A457370) announces an Equity Buyback for KRW 2,000 million worth of its shares.Hanchem Co,. Ltd. (KOSDAQ:A457370) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a trust contract with Shinyoung Securities Co., Ltd. The purpose of the program is to stabilize stock price and enhancing value of shareholders. The program will expire on August 29, 2025. As of February 2, 2025, the company had 0 shares in treasury within scope available for dividend and had 5 shares in treasury under other capacities.収支内訳Hanchem Co の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A457370 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Mar 2632,2605,1281,76257331 Dec 2533,8965,7731,74356430 Sep 2535,7015,1131,84056030 Jun 2537,5096,1171,79854931 Mar 2535,7035,7381,71254231 Dec 2436,6975,7671,70053530 Sep 2438,2257,2911,29250330 Jun 2433,9515,3951,21651331 Mar 2430,3364,7461,20452131 Dec 2326,9414,1611,12952831 Dec 2221,5133,18388446431 Dec 2117,9142,55980341331 Dec 2013,5931,509761031 Dec 1910,806952645031 Dec 179,034999598031 Dec 166,809-216540031 Dec 155,426-8276110質の高い収益: A457370は 高品質の収益 を持っています。利益率の向上: A457370の現在の純利益率 (15.9%)は、昨年(16.1%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A457370の収益は過去 5 年間で年間15.3%増加しました。成長の加速: A457370は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: A457370は過去 1 年間で収益成長率がマイナス ( -10.6% ) となったため、 Chemicals業界平均 ( -3.4% ) と比較することが困難です。株主資本利益率高いROE: A457370の 自己資本利益率 ( 8.8% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/10 05:30終値2026/07/10 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Hanchem Co,. Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Nov 19Third quarter 2025 earnings released: EPS: ₩175 (vs ₩373 in 3Q 2024)Third quarter 2025 results: EPS: ₩175 (down from ₩373 in 3Q 2024). Revenue: ₩8.16b (down 18% from 3Q 2024). Net income: ₩1.37b (down 42% from 3Q 2024). Profit margin: 17% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₩7,470, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 7.7% over the past year.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to ₩10,460, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 23% over the past year.
Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩14,320, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 75% over the past year.
New Risk • May 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (₩98.8b market cap, or US$65.8m).
Valuation Update With 7 Day Price Move • May 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩9,470, the stock trades at a trailing P/E ratio of 14.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 20% over the past year.
New Risk • Mar 27New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 33% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Market cap is less than US$100m (₩67.5b market cap, or US$44.7m).
お知らせ • Mar 17Hanchem Co,. Ltd., Annual General Meeting, Mar 27, 2026Hanchem Co,. Ltd., Annual General Meeting, Mar 27, 2026, at 09:30 Tokyo Standard Time. Location: conference room, 35, techno 9-ro, yuseong-gu, daejeon South Korea
Valuation Update With 7 Day Price Move • Mar 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,990, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 6.0% over the past year.
Buy Or Sell Opportunity • Mar 03Now 24% undervaluedOver the last 90 days, the stock has risen 17% to ₩8,990. The fair value is estimated to be ₩11,773, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 10%.
分析記事 • Jan 16Hanchem Co,. Ltd. (KOSDAQ:457370) Stock Rockets 37% As Investors Are Less Pessimistic Than ExpectedHanchem Co,. Ltd. ( KOSDAQ:457370 ) shareholders would be excited to see that the share price has had a great month...
分析記事 • Jan 13Hanchem Co (KOSDAQ:457370) Will Be Hoping To Turn Its Returns On Capital AroundWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩9,160, the stock trades at a trailing P/E ratio of 14.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Negligible returns to shareholders over past year.
お知らせ • Dec 03Hanchem Co,. Ltd. announces Annual dividendHanchem Co,. Ltd. announced Annual dividend of KRW 200.0000 per share, ex-date on December 29, 2025 and record date on December 31, 2025.
分析記事 • Nov 19There's No Escaping Hanchem Co,. Ltd.'s (KOSDAQ:457370) Muted EarningsWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") above 14x, you may consider...
Reported Earnings • Nov 19Third quarter 2025 earnings released: EPS: ₩175 (vs ₩373 in 3Q 2024)Third quarter 2025 results: EPS: ₩175 (down from ₩373 in 3Q 2024). Revenue: ₩8.16b (down 18% from 3Q 2024). Net income: ₩1.37b (down 42% from 3Q 2024). Profit margin: 17% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue.
分析記事 • Jul 14Here's Why Hanchem Co (KOSDAQ:457370) Can Manage Its Debt ResponsiblyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
お知らせ • Feb 21Hanchem Co,. Ltd., Annual General Meeting, Mar 28, 2025Hanchem Co,. Ltd., Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: conference room, 35, techno 9-ro, yuseong-gu, daejeon South Korea
お知らせ • Feb 04Hanchem Co,. Ltd. (KOSDAQ:A457370) announces an Equity Buyback for KRW 2,000 million worth of its shares.Hanchem Co,. Ltd. (KOSDAQ:A457370) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to a trust contract with Shinyoung Securities Co., Ltd. The purpose of the program is to stabilize stock price and enhancing value of shareholders. The program will expire on August 29, 2025. As of February 2, 2025, the company had 0 shares in treasury within scope available for dividend and had 5 shares in treasury under other capacities.